The computation of case fatality rate for novel coronavirus (COVID-19) based on Bayes theorem

Abstract

Background: When a new disease such starts to spread, the commonly asked questions are how deadly is it? and how many people are likely to die of this outbreak? The World Health Organization (WHO) announced in a press conference on January 29, 2020 that the death rate of COVID-19 was 2% on the case fatality rate (CFR). It was underestimated assuming no lag days from symptom onset to deaths while many CFR formulas have been proposed, the estimation on Bays theorem is worthy of interpretation. Hence, it is hypothesized that the over-loaded burdens of treating patients and capacities to contain the outbreak (LSBHRS) may increase the CFR. Methods: We downloaded COVID-19 outbreak numbers from January 21 to February 14, 2020, in countries/regions on a daily basis from Github that contains information on confirmed cases in >30 Chinese locations and other countries/regions. The pros and cons were compared among the 5 formula of CFR, including [A] deaths/confirmed; [B] deaths/(deaths + recovered); [C] deaths/(cases x days ago); [D] Bayes estimation based on [A] and the outbreak (LSBHRS) in each country/region; and [E] Bayes estimation based on [C] deaths/(cases x days ago). The coefficients of variance (CV = the ratio of the standard deviation to the mean) were applied to measure the relative variability for each CFR. A dashboard was developed for daily display of the CFR across each region. Results: The Bayes based on (A)[D] has the lowest CV (=0.10) followed by the deaths/confirmed (=0.11) [A], deaths/(deaths + recoveries) (=0.42) [B], Bayes based on (C) (=0.49) [E], and deaths/(cases x days ago) (=0.59) [C]. All final CFRs will be equal using the formula (from, A to E). A dashboard was developed for the daily reporting of the CFR. The CFR (3.7%) greater than the prior CFR of 2.2% was evident in LSBHRS, increasing the CFR. A dashboard was created to present the CFRs on COVID-19. Conclusion: We suggest examining both trends of the Bayes based on both deaths/(cases 7 days ago) and deaths/confirmed cases as a reference to the final CFR. An app developed for displaying the provisional CFR with the 2 CFR trends can improve the underestimated CFR reported by WHO and media.

Using the IPcase Index with Inflection Points and the Corresponding Case Numbers to Identify the Impact Hit by COVID-19 in China: An Observation Study

“…The results showed that Hong Kong, Shanghai, and Hubei are the top three cities most affected by COVID-19, with IPcase indices of 1744, 723, and 698; respectively, quite different from the results in IP or CNIC ( Figure 3 and Figure 4 ) alone in analyses. Using the single CNIC [ 2 , 3 ] to compare the negative impact of COVID-19 is problematic and unreasonable.…”

“…Which countries/regions were severely affected by COVID-19 is one of the most frequently asked questions. Using the number of reported cases is common, but not fair [ 2 , 3 ]. Several pandemic-prevention measures such as lockdowns, quarantines, mask-wearing, social distancing, contact reduction, and triggering bold policies on containment and mitigation have been implemented in several countries to flatten the curve of COVID-19 [ 4 ] cases and to decrease the strain on the public and health care systems in their areas as much as possible.…”

Mortality among the early cases of COVID-19 and its association with key comorbidities in a large state in South India

“…To calculate the adjusted CFR, we used the cumulative number of cases reported X days ago where X denotes the median number of days from diagnosis to death. 4 We calculated the median days from diagnosis to death by conducting survival analysis using the Kaplan-Meier estimate. 5 The cases which were reported as brought dead or dead at residence were not taken into consideration for this analysis.…”

Mortality indicators of COVID–19 in high burden states and cities of India: a review

“…CFR predominantly depends upon the number of cases who are diagnosed and labelled as 'cases', which in turn depends upon the testing rate, reporting rate, etc. 9,10 If a greater number of tests is performed, the denominator (used to calculate CFR) will keep increasing, and for a disease like COVID-19, with the number of asymptomatic/mildly symptomatic cases being high, it could capture many such asymptomatic/mildly symptomatic cases, and this would further lower the CFR. Moreover, the robustness of the diagnostic test also plays some role here in terms of false-positive rate, falsenegative rate, etc.…”